@oigathhs

oigathhs has been a member of Linktree for 3 years and joined in June 2023. The social media accounts linked to from oigathhs are: • Facebook • Instagram • YouTube • LinkedIn • X Besides social media accounts, oigathhs has populated their site with: • HHS-OIG Fugitives | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • oig.hhs.gov • Compliance | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Consumer Alert: Cardiovascular Testing | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • 2026 National Health Care Fraud Takedown | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Inaccurate Medicaid Managed Care Network Lists May Compromise State Oversight of Access to Maternal Health Care | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Employee Profile: Meridith Seife • Inaccurate Medicaid Managed Care Provider Directories May Limit Enrollees’ Access to Maternal Health Care | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Employee Profile: Melissa C. Tucker • www.justice.gov • Employee Profile: Amanda Sutter • Office of Public Affairs | Fraud Division Announces Federal–State Partnership in Ohio to Prosecute Fraud | United States Department of Justice • Employee Profile: Kofi Ansah-Brew • Hiring Attorney Advisors • tips.oig.hhs.gov • CMS Potentially Overpaid Medicare Advantage Organizations $462 Million Based on Certain Unsupported Acute Stroke Diagnosis Codes | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Office of Public Affairs | Minnesota Health Care Fraud Takedown Results in Charges Against 15 Defendants for Over $90M in Fraud | United States Department of Justice • Impacts of Vertical Integration in Medicare Part D on Sponsors’ Drug Costs, Pharmacy Reimbursement, and Enrollee Cost Sharing | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Unclear Medicare Requirements Led to Differing Interpretations of Inpatient Rehabilitation Facility Documentation, Coverage, and Billing Requirements | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Autism researcher extradited from Germany to face federal charges of stealing CDC grant money • Office of Public Affairs | The Fraud Division Launches West Coast Strike Force to Target Health Care Fraud Schemes Across Arizona, Nevada, and Northern California | United States Department of Justice • Most Nursing Homes Throughout the United States Do Not Have Adequate or Reliable Emergency Power Systems | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Office of Public Affairs | Opioid Manufacturer Purdue Pharma Sentenced for Fraud and Kickback Conspiracies | United States Department of Justice • USAJOBS - Job Announcement • FDA’s Efforts To Oversee and Mitigate the Risks of Compounded GLP-1 Drugs | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • USAJOBS - Search • Internship Opportunities | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Office of Public Affairs | National Partnership of Insurance Brokers and its Former Subsidiary Agree to Pay Over $135 Million For Affordable Care Act Enrollment Fraud Scheme | United States Department of Justice • Medicaid Fraud Control Units Annual Report: Fiscal Year 2025 | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Nursing Homes Inappropriately Diagnosed Residents with Schizophrenia to Mask the Misuse of Antipsychotic Drugs • Nursing Homes’ Inappropriate Use of Antipsychotic Drugs Poses a Risk to Residents • Owners and CEO of Wholesale Pharmaceutical Company Sentenced for Distributing More Than $92M of Black-Market HIV Drugs • Job Announcement: Deputy Inspector General for Audit Services • Psychosocial Characteristics and Their Association With Kidney Transplant Programs Waitlist Rates • Colorado Made at Least $77.8 Million in Improper Fee-for-Service Medicaid Payments for Applied Behavior Analysis Provided to Children • Former NFL Player and Laboratory Owner Convicted in $328M Genetic Testing Fraud Scheme • Toolkit: To Help Decrease Improper Payments in Medicare Advantage Through the Identification of High-Risk Diagnosis Codes • President of Insurance Brokerage Firm and CEO of Marketing Company Sentenced in $233M Affordable Care Act Enrollment Fraud Scheme that Preyed on Vulnerable Consumers • ACF’s $529 Million Sole Source Contract Award for Unaccompanied Alien Children Services Was Based on an Unsolicited Proposal, Double the Cost Estimate, and Noncompliant With Pre-Award Requirements | Office of Inspector General | Government Oversight | U.S • Fraud Tourists Plead Guilty to Minneapolis Medicaid Fraud • Medicare Advantage Industry Segment-Specific Compliance Program Guidance • Total Medicare Part B Spending on Lab Tests Rose in 2024, Driven by Increased Spending on Genetic Tests • Maine Made at Least $45.6 Million in Improper Fee-for-Service Medicaid Payments for Rehabilitative and Community Support Services Provided to Children Diagnosed With Autism | Office of Inspector General | Government Oversight | U.S. Department of Health a • HHS-OIG Fact Sheet • Saving Taxpayer Dollars in Fiscal Year 2025 • Fall 2025 Semiannual Report to Congress • 2025 Top Management & Performance Challenges Facing HHS | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services • Kaiser Permanente Affiliates Pay $556 Million to Resolve False Claims Act Allegations • Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme • Quick Tips for the List of Excluded Individuals/Entities • Thomas March Bell Inspector General of U.S. Department of Health and Human Services Biography • CEO of Health Care Software Company Sentenced for $1B Fraud Conspiracy • Illinois Made Unallowable Managed Care Capitation Payments on Behalf of Incarcerated Medicaid Enrollees • Trends in Dual-Eligible Enrollees’ Access to Drugs Under Part D, 2011-2025 • Excluding Noncovered Versions Would Have Substantially Lowered Fourth-Quarter 2025 Part B Payment Amounts for Stelara Biosimilars • Illinois Men Face Additional Charges for Health Care Fraud and Money Laundering Conspiracy • Medicare Improperly Paid Selected Optometrists for Services Provided to Enrollees at Nursing Facilities • Gaps in NIH’s Oversight Put Millions in Funding for Other Transactions at Greater Risk of Fraud, Waste, or Abuse • VRA Enterprises Agrees To Pay Over $17 Million For Allegedly Billing Medicare For Over-The-Counter COVID-19 Tests That Were Not Provided To Beneficiaries, Or That Were Sent To Beneficiaries Months After Being Billed To Medicare • CMS Put $11.2 Billion at Risk of Fraud, Waste, and Abuse by Not Properly Closing Contracts • Nearly All Skilled Nursing Services Provided by Pinnacle Multicare Nursing and Rehabilitation Center Did Not Meet Medicare Payment Requirements • The National Institutes of Health Needs to Improve the Cybersecurity of the All of Us Research Program to Protect Participant Data • Office of Inspector General’s Partnership With the Office of the Kentucky State Auditor of Public Accounts: State Auditor’s Report How Kentucky Failed to Prevent Over $800 Million of Medicaid Waste • HHS-OIG's Top Unimplemented Recommendations • CMS’s Special Focus Facility Program for Nursing Homes Has Not Yielded Lasting Improvements • Medicare Improperly Paid Suppliers $22.7 Million Over 7 Years for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Provided to Enrollees During Inpatient Stays • Compliance Resource Portal • Exclusions Program • Corporate Integrity Agreements • Medicare Could Have Saved $301.5 Million if Bundled Payment Rates for Opioid-Use-Disorder Treatment Services Had Reflected Services Provided to Enrollees • Many Medicare Advantage and Medicaid Managed Care Plans Have Limited Behavioral Health Provider Networks and Inactive Providers • Avoiding Medicare and Medicaid Fraud and Abuse: A Roadmap for New Physicians • HRSA Rural Communities Opioid Response Program Award Recipients Generally Met All Core Activities and Benchmarks • Deficiencies With Incorporating Required Cybersecurity Language in HHS Contracts and Timeliness of Contractor Incident Reporting • Two Florida Men Charged for $34.8M Fraud Scheme Targeting Medicare Beneficiaries • Guatemalan National Illegally Residing in the United States Indicted on Fraud Charges Related to the Sponsorship of Unaccompanied Alien Child • Serious Falls Resulting in Hospitalization Among Medicare-Enrolled Nursing Home Residents, July 2022–June 2023 • Nursing Homes Failed To Report 43 Percent of Falls With Major Injury and Hospitalization Among Their Medicare-Enrolled Residents • Most Children Enrolled in Medicaid Did Not Receive Timely Suicide-Related Followup Care • Medicare Part B Payment Trends for Skin Substitutes Raise Major Concerns About Fraud, Waste, and Abuse • Some Medicaid Managed Care Plans Made Few or No Referrals of Potential Provider Fraud • Most Health Centers Provide Some Behavioral Health Services to Patients With Substance Use Disorder, Despite Facing Challenges That Limit Comprehensive Treatment • Billing for Remote Patient Monitoring in Medicare • Troy Health, Inc. Enters Non-Prosecution Agreement and Admits to Fraudulently Enrolling Medicare Beneficiaries and Identity Theft • Alabama Did Not Always Verify Selected Nursing Homes’ Compliance With Background Check Requirements • Fugitive Profile: Herbert “Herb” Kimble • During Hurricanes Fiona and Ian, HHS Helped Minimize Disruptions to Medical Services at Select Health Care Facilities • Florida Did Not Fully Comply With Federal Reporting and Oversight Requirements for Its Opioid Response Grant • CMS Should Take Additional Actions To Help Hospitals Prepare for a Future Emerging Infectious Disease Outbreak • Hospitals Reported Few Captured Patient Harm Events to CMS and States • Hospitals Did Not Capture Half of Patient Harm Events, Limiting Information Needed to Make Care Safer • Louisiana Nurse Practitioner Convicted of $12M Medicare Fraud Scheme • Potential Cost Savings: $50 Billion • Florida Nonprofit Founder and Accountant Charged with Stealing Over $100M from Special Needs Victims • National Health Care Fraud Takedown Results in 324 Defendants Charged in Connection with Over $14.6 Billion in Alleged Fraud • $1 Billion in Potential Cost Savings in HHS Programs • Availability of Surveyed Behavioral Health Providers to Treat New Patients Enrolled in Medicare and Medicaid • $1.6 Billion in Potential Savings in HHS Programs • $6.6 Billion in Potential Savings in HHS Programs • Eleven of Thirty Selected Hospitals Did Not Comply With Terms and Conditions and Federal Requirements for Expending Provider Relief Fund Payments • $6.9 Billion in Potential Savings in HHS Programs • $1 Billion in Potential Cost Savings: Legislative Action • HHS’s Grant Payment System Lacked Effective Internal Controls To Prevent $7.8 Million in Fraud, and HHS Has Begun Taking Corrective Actions To Reduce Fraud Risk • $7.7 Billion in Potential Cost Savings: Legislative Action • $1.3 Billion in Potential Cost Savings in HHS Programs: Legislative Actions • Two Charged in $227M Medicare Fraud Scheme • Spring 2025 Semiannual Report to Congress • $2.9 Billion in Potential Cost Savings in HHS Programs: Legislative Actions • Medicare Payments for Evaluation and Management Services Provided on the Same Day as Eye Injections Were at Risk for Noncompliance With Medicare Requirements • $50 Billion in Potential Cost Savings: HHS Actions • Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay $3.6M to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product • $4.9 Billion in Potential Cost Savings in HHS Programs: Legislative Actions • Maryland Did Not Comply With Federal Waiver and State Requirements at 20 Adult Day Care Facilities Audited • CMS Is Not Systematically Tracking Whether States Return Federal Shares of Medicaid Managed Care Remittances • $6.9 Billion in Potential Cost Savings in HHS Programs: Legislative Actions • Most Medicare Part D Plans’ Formularies Included Humira Biosimilars for 2025 • $17 Billion in Potential Cost Savings in HHS Programs: Legislative Actions • U.S. Attorney Announces $202 Million Settlement With Gilead Sciences For Using Speaker Programs To Pay Kickbacks To Doctors To Induce Them To Prescribe Gilead’s Drugs • Walgreens Agrees to Pay Up to $350 Million for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government • Fewer than One in Five Medicare Enrollees Received Medication to Treat Their Opioid Use Disorder • Medicare Advantage Provider Seoul Medical Group and Related Parties to Pay Over $62M to Settle False Claims Act Suit • Medicare Administrative Contractors Did Not Consistently Meet Medicare Cost Report Oversight Requirements • SAMHSA’s FindTreatment.gov Contained Some Inaccurate Information on Substance Use and Mental Health Treatment Facilities • ACF Used Contractor Personnel To Perform Inherently Governmental Functions and Paid Millions in Potentially Unallowable Costs • State Survey Agencies Need Additional Guidance to Assess Nursing Home Emergency Preparedness Programs • Medicaid Fraud Control Units Annual Report: Fiscal Year 2024 • Medicare and Medicaid Payments to Providers Are at Risk of Diversion Through Electronic Funds Transfer Fraud Schemes • CDC Lacked Documentation for Its Redirections of PEPFAR Funds to Support the COVID-19 Response • Medicare Paid Claims That Were Not in Accordance With the Over-the- Counter COVID-19 Test Kits Demonstration Quantity Limitation • Medicare Contractors Did Not Use Complete and Timely Utilization Data When Making Part B Coverage Determinations for Stelara • Not All Medicare Enrollees Are Continuing Treatment for Opioid Use Disorder • Medicare Improperly Paid Suppliers for Intermittent Urinary Catheters • BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the Government for Medically Unnecessary Blood Tests • How FDA Used Its Accelerated Approval Pathway Raised Concerns in 3 of 24 Drugs Reviewed • Justice Department Files Nationwide Lawsuit Alleging CVS Knowingly Dispensed Controlled Substances in Violation of the Controlled Substances Act and the False Claims Act • Medicaid Gross Spending on 10 Selected Diabetes and 2 Selected Weight Loss Drugs Totaled More Than $9 Billion in 2023, an Increase of 540 Percent From 2019 • Indiana Made at Least $56 Million in Improper Fee-for-Service Medicaid Payments for Applied Behavior Analysis Provided to Children Diagnosed With Autism • Justice Department Announces Resolution of Criminal and Civil Investigations into McKinsey & Company’s Work with Purdue Pharma L.P.; Former McKinsey Senior Partner Charged with Obstruction of Justice • Staffing Shortages Limited IHS’s Capacity To Effectively Administer Much-Needed Sanitation Projects Funded by the Infrastructure Investment and Jobs Act • Public Health and Human Service Grants and Contracts | HHS-OIG • Fall 2024 Semiannual Report to Congress • CDC’s and SAMHSA’s Processes for and Challenges With Compiling Data for the National Drug Control Assessment • Seven of Thirty Hospices Reviewed Did Not Comply or May Not Have Complied With Terms and Conditions and Federal Requirements for Provider Relief Fund Payments • The Office for Civil Rights Should Enhance Its HIPAA Audit Program to Enforce HIPAA Requirements and Improve the Protection of Electronic Protected Health Information • The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern • 2024 Top Management & Performance Challenges Facing HHS • Review of the Department of Health and Human Services’ Compliance with the Federal Information Security Modernization Act of 2014 for Fiscal Year 2024 • Medicare Improperly Paid Acute-Care Hospitals an Estimated $190 Million Over 5 Years for Outpatient Services Provided to Hospice Enrollees • Nursing Facility Industry Segment-Specific Compliance Program Guidance • Maine Did Not Comply With Screening, Assessment, and Investigation Requirements for Responding to Reports of Child Abuse and Neglect • Medicare Advantage: Questionable Use of Health Risk Assessments Continues To Drive Up Payments to Plans by Billions • HHS-OIG: Strengthening Cybersecurity in Health Care • States Could Better Leverage Coverage and Access Requirements To Promote Maternal Health Care Access in Medicaid Managed Care • 27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico • Systemic and Operational Challenges Hinder Efforts to Ensure HIV Care for Medicaid Enrollees • Additional Oversight of Remote Patient Monitoring in Medicare Is Needed • OIG Companion Product - Medicare and Medicaid Enrollees in Many High-Need Areas May Lack Access to Medications for Opioid Use Disorder • Medicare and Medicaid Enrollees in Many High-Need Areas May Lack Access to Medications for Opioid Use Disorder • The Emergency Medical Treatment and Labor Act (EMTALA) • New Mexico Did Not Ensure Attendants Were Qualified To Provide Personal Care Services, Putting Medicaid Enrollees at Risk • Massachusetts Opioid Treatment Program Services Met Many of the Federal and State Requirements • Utah Generally Completed Medicaid Eligibility Actions During the Unwinding Period in Accordance With Federal and State Requirements • South Carolina Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations • Natural Disaster Response • Contract Fraud • Certain For-Profit Nursing Homes May Not Have Complied With Federal Requirements Regarding the Infection Preventionist Position • Recommendations Tracker • EmpowHER: A Career Fair with HHS-OIG for Women Students • Medicaid Fraud Control Units • Telehealth Oversight • Medicare and Some Enrollees Paid Substantially More When Stelara Was Covered Under Part D Versus Part B • Alaska Medicaid Fraud Control Unit: 2023 Inspection • Compliance Program Infrastructure: The Seven Elements • West Virginia Medicaid Fraud Control Unit: 2023 Inspection • Hospice • Compliance Resources • EA: Rite Aid Corporation and Elixir Insurance Company Agree to Pay $101M to Resolve Allegations of Falsely Reporting Rebates • Cybersecurity • Impact Brief: Medicare Advantage Fraud • Many States Lack Information To Monitor Maltreatment in Residential Facilities for Children in Foster Care • Fraud Alert: Grant Scams • Drug Spending • 2024 Nationwide Health Care Fraud Enforcement Action • Operation C.A.R.E. • HHS-OIG's Office Of Counsel To The Inspector General 2024 Fall Health Care Fraud And Abuse Legal Internship • Spring 2024 Semiannual Report to Congress • Nursing Homes • New Report: Plans and Enrollment Often Fell Short for Underrepresented Groups in a Sample of NIH-Funded Clinical Trials • Adverse Events • A Roadmap for New Physicians • New Opioid Review Map Series • Three defendants sentenced in fraudulent nursing diploma scheme • General Compliance Program Guidance • HHS-OIG Careers • Examining How Improper Payments Cost Taxpayers Billions and Weaken Medicare and Medicaid • Impact Brief: Medicare Advantage Prior Authorization • A Resource Guide for Using Medicare's Enrollment Race and Ethnicity Data • Managed Care • Report: A Lack of Behavioral Health Providers in Medicare & Medicaid Impedes Enrollees’ Access to Care • Report: Top Management & Performance Challenges Facing HHS • Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services